Triple
T5932480
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ICH Q9 Quality Risk Management |
E131968
|
entity |
| Predicate | regionallyImplementedBy |
P11942
|
FINISHED |
| Object | European Medicines Agency |
E3950
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Medicines Agency | Statement: [ICH Q9 Quality Risk Management, regionallyImplementedBy, European Medicines Agency]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: European Medicines Agency Context triple: [ICH Q9 Quality Risk Management, regionallyImplementedBy, European Medicines Agency]
-
A.
European Medicines Agency
chosen
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
B.
European medicines regulatory authorities
European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
-
C.
Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
-
D.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
E.
Committee for Herbal Medicinal Products
The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: regionallyImplementedBy Context triple: [ICH Q9 Quality Risk Management, regionallyImplementedBy, European Medicines Agency]
-
A.
isRegionOf
Indicates that one entity is a geographic or administrative region belonging to, contained within, or associated with another entity.
-
B.
regionSpecialization
Indicates that a region is designated or recognized as being particularly focused on, adapted to, or specialized in a specific function, activity, or domain.
-
C.
regionalVariantOf
chosen
Indicates that one entity is a version or form of another that is specific to a particular geographic region or locale.
-
D.
regionRuled
Indicates that a particular region is governed or controlled by a specified ruler or authority.
-
E.
regionException
Indicates an exception or exclusion to a rule, condition, or classification that applies specifically to a certain region or set of regions.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0085b75e88190a632f9691f9da48b |
completed | March 22, 2026, 3:18 p.m. |
| NER | Named-entity recognition | batch_69c03f26f51881908cc253fe5775a1fc |
completed | March 22, 2026, 7:12 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c5e399f2ec81908e2e38b9fbf8b56a |
completed | March 27, 2026, 1:55 a.m. |
| PD | Predicate disambiguation | batch_69c03355caf08190b960563a1aed23f9 |
completed | March 22, 2026, 6:22 p.m. |
Created at: March 22, 2026, 4 p.m.